Difference between revisions of "Template:Antiarrhythmic agents"

From blackwiki
Jump to navigation Jump to search
m (67 revisions imported)
 
(63 intermediate revisions by 30 users not shown)
Line 1: Line 1:
<br style="clear: both"/>
+
{{Navbox
{| class="toccolours" align="center" style="margin: 0 2em 0 2em; color: #8888aa"
+
| name  = Antiarrhythmic agents
|-
+
| title = [[Antiarrhythmic agent]]s ([[ATC code C01#C01B|C01B]])
! align="center" colspan="3" style="color: grey; background: #ccccff" | [[Antiarrhythmic agent]]s ([[ATC_code_C01#C01B_Antiarrhythmics.2C_class_I_and_III|C01B]])<small><small class="editlink noprint plainlinksneverexpand">[{{SERVER}}{{localurl:Template:Antiarrhythmic agents|action=edit}} edit]</small></small>
+
| state = {{{state|autocollapse}}}
|-
+
|listclass = hlist
| '''class Ia:''' ||
 
[[Ajmaline]],
 
[[Disopyramide]],
 
[[Prajmaline]],
 
[[Procainamide]],
 
[[Quinidine]],
 
[[Sparteine]]
 
|-
 
| '''class Ib:''' ||
 
[[Aprindine]],
 
[[Lidocaine]],
 
[[Mexiletine]],
 
[[Tocainide]]
 
|-
 
| '''class Ic:''' ||
 
[[Encainide]],
 
[[Flecainide]],
 
[[Lorcainide]],
 
[[Moricizine]],
 
[[Propafenone]]
 
|-
 
| '''class II:''' ||
 
[[Propranolol]],
 
[[Metoprolol]],
 
[[Nadolol]],
 
[[Atenolol]],
 
[[Acebutolol]],
 
[[Pindolol]],
 
[[Sotalol]]
 
''see [[Beta blockers]] ([[ATC code C07|C07]])''
 
|-
 
| '''class III:''' ||
 
[[Amiodarone]],
 
[[Bretylium|Bretylium tosilate]],
 
[[Bunaftine]],
 
[[Dofetilide]],
 
[[Ibutilide]]
 
|-
 
| '''class IV:''' ||
 
[[Verapamil]],
 
[[Ditiazern]]
 
''see [[Calcium channel blocker]]s ([[ATC code C08|C08]])''
 
|-
 
| '''class V:''' ||
 
[[Adenosine]],
 
[[Digoxin]]
 
  
|}<noinclude>
+
|group1  = [[Channel blocker]]s
[[Category:Drug navigational boxes|{{PAGENAME}}]]
+
|list1  = {{Navbox|subgroup
 +
 
 +
| group1 = [[Antiarrhythmic agent#Class I agents|class I]]<BR>([[sodium channel blocker|Na<sup>+</sup> channel blockers]])
 +
| list1  = {{Navbox|subgroup
 +
 
 +
  | group1 = class Ia ([[Cardiac action potential#Phase 0|Phase 0]]→ and [[Cardiac action potential#Phase 3|Phase 3]]→)
 +
  | list1  =
 +
* [[Ajmaline]]
 +
* [[Disopyramide]]
 +
* [[Dihydroquinidine|Hydroquinidine]]
 +
* [[Lorajmine]]
 +
* [[Prajmaline]]
 +
* [[Procainamide]]<sup>#</sup>
 +
* [[Quinidine]]<sup>#</sup>
 +
* [[Sparteine]]
 +
 
 +
  | group2 = class Ib ([[Cardiac action potential#Phase 3|Phase 3]]←)
 +
  | list2  =
 +
* ''[[Intravenous therapy|IV]]''
 +
** [[Lidocaine]]<sup>#</sup>
 +
* ''[[enteral]]''
 +
** [[Aprindine]]
 +
** [[Mexiletine]]
 +
** [[Tocainide]]
 +
 
 +
  | group3 = class Ic ([[Cardiac action potential#Phase 0|Phase 0]]→)
 +
  | list3  =
 +
* [[Encainide]]<sup>‡</sup>
 +
* [[Ethacizine]]
 +
* [[Flecainide]]
 +
* [[Indecainide]]<sup>‡</sup>
 +
* [[Lorcainide]]
 +
* [[Moracizine]]<sup>‡</sup>
 +
* [[Propafenone]]
 +
 
 +
  }}
 +
 
 +
| group3 = [[Antiarrhythmic agent#Class III agents|class III]]<BR>([[Cardiac action potential#Phase 3|Phase 3]]→, [[potassium channel blocker|K<sup>+</sup> channel blockers]])
 +
| list3  =
 +
* [[Amiodarone]]
 +
* [[Bretylium]]
 +
* [[Bunaftine]]
 +
* [[Celivarone]]<sup>†</sup>
 +
* [[Dofetilide]]
 +
* [[Dronedarone]]
 +
* [[E-4031]]<sup>†</sup>
 +
* [[Ibutilide]]
 +
* [[Nifekalant]]
 +
* [[Sotalol]]
 +
* [[Tedisamil]]
 +
* [[Vernakalant]]
 +
 
 +
| group4 = [[Antiarrhythmic agent#Class IV agents|class IV]]<br/>([[Cardiac action potential#Phase 4|Phase 4]]→, [[calcium channel blocker|Ca<sup>2+</sup> channel blockers]])
 +
| list4  =
 +
* [[Diltiazem]]
 +
* [[Verapamil]]<sup>#</sup>
 +
 
 +
}}
 +
 
 +
|group2  = [[Receptor (biochemistry)|Receptor]] [[agonist]]s<BR>and [[Receptor antagonist|antagonist]]s
 +
|list2  = {{Navbox|subgroup
 +
 
 +
| group2 = [[Antiarrhythmic agent#Class II agents|class II]]<br/>([[Cardiac action potential#Phase 4|Phase 4]]→, [[beta blocker|β blocker]]s)
 +
| list2  =
 +
* [[Nadolol]]
 +
* [[Pindolol]]
 +
* [[Propranolol]]
 +
* ''cardioselective''
 +
** [[Acebutolol]]
 +
** [[Atenolol]]
 +
** [[Esmolol]]
 +
** [[Metoprolol]]
 +
 
 +
| group5 = [[adenosine A1 receptor|A<sub>1</sub> agonist]]
 +
| list5  =
 +
* [[Adenosine]]
 +
* [[Benzodiazepine]]s
 +
* [[Barbiturate]]s
 +
 
 +
| group6 = [[Muscarinic acetylcholine receptor M2|M<sub>2</sub>]]
 +
| list6  =
 +
* [[muscarinic antagonist]]: [[Atropine]]
 +
* [[Disopyramide]]
 +
* [[Quinidine]]<BR>[[muscarinic agonist]]: [[Digoxin]]
 +
 
 +
| group7 = [[Adrenergic receptor#.CE.B1 receptors|α receptors]]
 +
| list7  =
 +
* [[Amiodarone]]
 +
* [[Bretylium]]
 +
* [[Quinidine]]
 +
* [[Verapamil]]
 +
 
 +
}}
 +
 
 +
| group8 = [[Ion transporter]]s
 +
| list8  = {{Navbox|subgroup
 +
 
 +
| group1 = [[Na+/K+-ATPase|Na<sup>+</sup>/ K<sup>+</sup>-ATPase]]
 +
| list1  =
 +
* [[Digitoxin]]
 +
* [[Digoxin]]
 +
* [[Ouabain]]
 +
 
 +
}}
 +
 
 +
| group9 =
 +
| list9  = {{PharmNavFootnote}}
 +
 
 +
}}<noinclude>
 +
{{collapsible option}}
 +
[[Category:Antiarrhythmic agents]]
 +
[[Category:Drug templates by ATC]]
 
</noinclude>
 
</noinclude>

Latest revision as of 14:15, 22 October 2020

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Antiarrhythmic agents|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Antiarrhythmic agents|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Antiarrhythmic agents|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.